Global Antibacterial Drugs Market Overview :
“The global Antibacterial Drugs market size is expected to be worth around US$ 234.5 million by 2021 from US$ 141.2 million in 2031, growing at a CAGR of 5.19% during the forecast period 2021 to 2031.”
The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global antibacterial drugs market report has been segmented on the basis of drug class, route of administration, distribution channel, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analysed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Harmful bacteria reproduced in the body, releases toxins that can damage body tissues. These harmful bacteria are also called as pathogenic bacteria because they cause disease and illnesses like strep throat, tuberculosis, staph infections, cholera, and food poisoning. Antibacterial is a type of antimicrobial drug which is used in the treatment and prevention of bacterial infections. Antibacterial drugs either kill or inhibit the growth of bacteria. Antibacterial drugs can be semi-synthetic, synthetic, or naturally occurring.
Increasing prevalence of bacterial infections and disease across the globe is a major factor expected to support the growth of the global antibacterial drugs market over the forecast period.
Increasing healthcare expenditure and companies focusing on clinical development of drug for treatment of serious bacterial infections is other factor expected to propel growth of target market over the forecast period. Increasing number of product approval and subsequent launch of the products in market is other factor expected to boost growth of the market over the forecast period.
Companies can focus on manufacturing novel antibacterial drugs which have fewer side effects and improved efficacy, is expected to create lucrative opportunities for players operating in the target market.
Based on distribution channel, the global antibacterial drugs market is segmented based on hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies segment accounts major revenue share of the market.
North America market dominates the global antibacterial drugs market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to presence of significant market players in the region. Europe accounts for second-largest revenue share contribution to the global antibacterial drugs market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively.
The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. Increasing number of healthcare infrastructure and increasing prevalence of bacterial infections, will in turn drive demand for antibacterial drugs, which thereby drives growth of the market in the region over the forecast period.
Global Antibacterial Drugs Market Segmentation:
Global antibacterial drugs market segmentation, by drug class:
- B – lactams
Global antibacterial drugs market segmentation, by route of administration:
Global antibacterial drugs market segmentation, by distribution channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global antibacterial drugs market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Allergan, Plc.
- Novartis AG
- Bristol Myers Squibb Company
- Johnson and Johnson
- Merck & Company, Inc.
- GlaxoSmithKline Plc.
- Sanofi SA
- Pfizer Inc.
- Hoffmann-La Roche AG
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!